Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDA-002 in Diabetic Peripheral Neuropathy
NCT02552277Phase 2Completed
- Sponsor
- Celularity Inc.
- Start
- Oct 2015
- Primary completion
- Mar 2017
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of cenplacel in diabetic peripheral neuropathy (DPN), sponsored by Celularity Inc.. Started Oct 2015; status: completed.
02
Drugs
cenplacel
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT02552277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02552277.